Clinical Data Phase 2 Active Comparator, Double-Blinded, Placebo-Controlled, Multi-Center Trial of RT002 Injectable Botulinum Toxin Type A for the Treatment of Glabellar Lines - 6-month duration of effect is statistically significant compared to BOTOX® Cosmetic - - All dose levels of RT002 achieved highly statistically significant, investigator-reported efficacy compared to placebo at Week 4 - - All dose levels of RT002 appear to be safe and well tolerated -